Mammography News and Research

RSS
A mammogram is a safe test used to look for any problems with a woman's breasts. The test uses a special, low-dose x-ray machine to take pictures of both breasts. The results are recorded on x-ray film or directly onto a computer for a radiologist to examine.

Mammograms allow the doctor to have a closer look for breast lumps and changes in breast tissue. They can show small lumps or growths that a doctor or woman may not be able to feel when doing a clinical breast exam. "Mammography" is the best screening tool that doctors have for finding breast cancer.

If a lump is found, your doctor may order other tests, such as ultrasound or a biopsy--a test where a small amount of tissue is taken from the lump and area around the lump. The tissue is sent to a lab to look for cancer or changes that may mean cancer is likely to develop. Breast lumps or growths can be benign (not cancer) or malignant (cancer). Finding breast cancer early means that a woman has a better chance of surviving the disease. There are also more choices for treatment when breast cancer is found early.
Researchers discover molecules that differentiate early-stage breast tumors from invasive cancer

Researchers discover molecules that differentiate early-stage breast tumors from invasive cancer

VuCOMP receives PMA for M-Vu CAD system

VuCOMP receives PMA for M-Vu CAD system

Majority of women fail to follow recommended MRI breast screening

Majority of women fail to follow recommended MRI breast screening

Capital Health installs GE Discovery NM 750b scanner at N.J. Hopewell medical center

Capital Health installs GE Discovery NM 750b scanner at N.J. Hopewell medical center

Hologic first quarter revenues increase 9.3% to $472.7 million

Hologic first quarter revenues increase 9.3% to $472.7 million

Fewer getting screened for common cancers: CDC report

Fewer getting screened for common cancers: CDC report

UCSD receives approval to acquire NVCI

UCSD receives approval to acquire NVCI

Nashville General Hospital at Meharry, Sectra announce multi-year agreement

Nashville General Hospital at Meharry, Sectra announce multi-year agreement

Obesity linked to higher rates of prostrate cancer screening across race/ethnicity and gender

Obesity linked to higher rates of prostrate cancer screening across race/ethnicity and gender

Cancer death rates declining - still room for improvement: Report

Cancer death rates declining - still room for improvement: Report

iCAD enters $15M debt facility agreement with Deerfield Management

iCAD enters $15M debt facility agreement with Deerfield Management

CHEST Foundation awards $100,000 for development of blood test for lung cancer

CHEST Foundation awards $100,000 for development of blood test for lung cancer

Mammography appears to detect women with low-risk breast cancer

Mammography appears to detect women with low-risk breast cancer

SonoCiné AWBU effective in detecting small cancers not detectable with mammography

SonoCiné AWBU effective in detecting small cancers not detectable with mammography

Hologic receives FDA approval for Cervista HTA system to detect cervical cancer

Hologic receives FDA approval for Cervista HTA system to detect cervical cancer

Book on hot health topics

Book on hot health topics

Risk of breast cancer in the genetically predisposed

Risk of breast cancer in the genetically predisposed

HCI earns NCI's Center for Quantitative Imaging Excellence certification

HCI earns NCI's Center for Quantitative Imaging Excellence certification

Breast cancer risks and management updates

Breast cancer risks and management updates

Study contradicts premise of framing effect on making health decisions

Study contradicts premise of framing effect on making health decisions

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.